Clinical trial

Interleukin-1 Blockade in Recently Decompensated Heart Failure

NCT01936909

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2017-12-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Anakinra (weeks 1-2)DRUG

Anakinra (weeks 3-12)DRUG

PlaceboDRUG

Sponsors & collaborators

Virginia Commonwealth Universitylead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

RichmondVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01936909 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.